Alerts in the EHR System May Help Bridge the 17-year Gap Between Publication of Evidence-Based Guidelines and Consistent Implementation in Practice by Healthcare Providers

<p>In this episode, we are joined by Dr. Ralph J. Riello III, PharmD, BCPS, Clinical Pharmacy Specialist, Cardiorenal &amp; Metabolism, Yale School of Medicine, and Dr. Nihar Desai, MD, MPH, Associate Professor, Yale School of Medicine, Vice Chief, Cardiovascular Medicine, to discuss the key findings from the PROMPT-Lipid Trial.</p><p></p><p>The PROMPT-LIPID trial was designed to evaluate whether automated electronic alerts with guideline-based recommendations can help improve the management of hyperlipidemia among patients with established atherosclerotic cardiovascular disease at very high risk for cardiovascular events.</p><p></p><p>This episode is sponsored by <a href="https://www.amgen.com/">Amgen</a>.</p>